DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Ezekowitz MD, Pollack Jr CV, Halperin JL. , et al.
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.
Eur Heart J 2018;
39 (32) 2959-2971
We do not assume any responsibility for the contents of the web pages of other providers.